Trials / Conditions / Painful Bladder Syndrome

Painful Bladder Syndrome

42 registered clinical trials studyying Painful Bladder Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome NCT06096597	David Sheyn	Phase 2 / Phase 3
Recruiting	Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment NCT06299683	Vanderbilt University Medical Center	N/A
Recruiting	Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA NCT05754190	Brown University	—
Recruiting	The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) NCT05726786	Centre Hospitalier Universitaire Vaudois	Phase 3
Terminated	IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone NCT04313972	Endeavor Health	Phase 4
Completed	Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04275297	Vanderbilt University Medical Center	N/A
Completed	Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome NCT03755375	University of Sao Paulo General Hospital	N/A
Terminated	Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder NCT03143920	University of California, San Diego	EARLY_Phase 1
Active Not Recruiting	Bladder Directed vs. Pelvic Floor Therapy in IC/BPS NCT02870738	Corewell Health East	Phase 2
Unknown	A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladde NCT02868775	Philadelphia Urosurgical Associates	—
Completed	Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial Cystitis NCT03069053	Fondazione IRCCS Policlinico San Matteo di Pavia	—
Unknown	Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome NCT02858453	Aquinox Pharmaceuticals (Canada) Inc.	Phase 3
Completed	A Pilot Study Investigating the Use of a Therapeutic Wand in Addition to Physiotherapy for Bladder Pain Syndro NCT02743962	University of Bradford	N/A
Completed	Reduction of Bladder Injection Pain With Belladonna Opiate Suppository NCT02600715	Edgar LeClaire, MD	Phase 4
Completed	Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS NCT02550561	University of California, Irvine	N/A
Completed	A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome NCT02411110	Allergan	Phase 2
Terminated	Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Pai NCT02517996	Johns Hopkins University	N/A
Completed	Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome NCT02457182	University of New Mexico	N/A
Completed	Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial NCT02232282	Loyola University	N/A
Completed	A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndro NCT02856022	Shanghai Institute of Acupuncture, Moxibustion and Meridian	N/A
Withdrawn	Microbiome of Urologic Chronic Pelvic Pain Syndrome NCT03027076	Johns Hopkins University	—
Unknown	Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome NCT01838486	Assaf-Harofeh Medical Center	N/A
Completed	Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC NCT05223244	Endeavor Health	Phase 4
Unknown	Identifying Predictors of Treatment Success in Painful Bladder Syndrome NCT01410461	Rambam Health Care Campus	—
Unknown	Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder NCT01312259	Pelvic and Sexual Health Institute	Phase 4
Unknown	Female Chronic Pelvic Pain NCT01255345	Copenhagen University Hospital at Herlev	—
Completed	OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) NCT01197261	Mundipharma Research GmbH & Co KG	Phase 2
Terminated	Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial NCT04268810	National Multiple Sclerosis Center	Phase 4
Completed	Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome NCT00919113	Watson Pharmaceuticals	Phase 2
Completed	Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome NCT01294878	Fondazione IRCCS Policlinico San Matteo di Pavia	Phase 3
Completed	An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cys NCT00739739	Pfizer	Phase 2
Completed	Physical Therapy in Women With Interstitial Cystitis NCT00733603	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A
Completed	Sensory Processing in Subjects With Painful Bladder Syndrome NCT00903643	University of Alabama at Birmingham	—
Terminated	Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis NCT00517868	Urigen	Phase 2
Terminated	A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . NCT00451867	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 3
Completed	Physical Therapy Trial for Pelvic Pain NCT00434343	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A
Completed	Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. NCT00775281	Insel Gruppe AG, University Hospital Bern	—
Completed	Linkage Analysis in Interstitial Cystitis NCT00675298	Beth Israel Deaconess Medical Center	—
Completed	URACYST® For the Treatment of GAG Deficient Interstitial Cystitis NCT00150488	Dr. J. Curtis Nickel	N/A
Completed	Genetics of Interstitial Cystitis NCT00237081	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—
Completed	Botox as a Treatment for Interstitial Cystitis in Women NCT00194610	University of Washington	Phase 4
Completed	Diagnostic Challenges in IC (and Male CPPS) NCT00672087	Beth Israel Deaconess Medical Center	—